Next Article in Journal
Beet Stalks and Leaves (Beta vulgaris L.) Protect Against High-Fat Diet-Induced Oxidative Damage in the Liver in Mice
Previous Article in Journal
Zinc Deficiency among Lactating Mothers from a Peri-Urban Community of the Ecuadorian Andean Region: An Initial Approach to the Need of Zinc Supplementation
Previous Article in Special Issue
Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases

Para-probiotics for Preterm Neonates—The Next Frontier

Department of Neonatology, Nepean Hospital, Kingswood, NSW 2747, Australia
Sydney Medical School Nepean, University of Sydney, Kingswood, NSW 2747, Australia
Department of Neonatology, King Edward Memorial Hospital for Women, Perth, WA 6008, Australia
Author to whom correspondence should be addressed.
Nutrients 2018, 10(7), 871;
Received: 29 April 2018 / Revised: 28 June 2018 / Accepted: 2 July 2018 / Published: 5 July 2018
(This article belongs to the Special Issue Prebiotics and Probiotics)
Current evidence supports the use of probiotics in preterm neonates for prevention of necrotizing enterocolitis, mortality and late onset sepsis. Despite the strong evidence, the uptake of this intervention has not been universal due to concerns including probiotic sepsis, pro-inflammatory response and transmission of antibiotic resistance. Critically ill extremely preterm neonates with potentially compromised gut integrity are at higher risk of probiotic sepsis due to translocation. In most countries, probiotics are sold as food supplements with poor quality control. The traditional definition of probiotics as “live microorganisms” has been challenged as many experts have questioned the importance of viability in the context of the beneficial effects of probiotics. Paraprobiotics (ghost probiotics), are defined as non-viable microbial cells (intact or broken) or crude cell extracts (i.e., with complex chemical composition), which, when administered (orally or topically) in adequate amounts, confer a benefit on the human or animal consumer. Current evidence indicates that paraprobiotics could be safe alternatives to probiotics in preterm neonates. High-quality pre-clinical and clinical studies including adequately powered randomised controlled trials (RCTs) are warranted in preterm neonates to explore this new frontier. View Full-Text
Keywords: infant; newborn; probiotics; review; sepsis infant; newborn; probiotics; review; sepsis
MDPI and ACS Style

Deshpande, G.; Athalye-Jape, G.; Patole, S. Para-probiotics for Preterm Neonates—The Next Frontier. Nutrients 2018, 10, 871.

AMA Style

Deshpande G, Athalye-Jape G, Patole S. Para-probiotics for Preterm Neonates—The Next Frontier. Nutrients. 2018; 10(7):871.

Chicago/Turabian Style

Deshpande, Girish, Gayatri Athalye-Jape, and Sanjay Patole. 2018. "Para-probiotics for Preterm Neonates—The Next Frontier" Nutrients 10, no. 7: 871.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop